Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Operating Expenses (2013 - 2026)

Scynexis' (SCYX) quarterly Operating Expenses came in at $8.0 million in Q2 2026, down 26.68% on a YoY basis from $10.9 million in Q2 2025, and down 52.71% quarter-over-quarter from $16.9 million in Q1 2026.

Analysis

Scynexis (SCYX) Operating Expenses (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Operating Expenses for 14 consecutive years, with $8.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Expenses fell 26.68% year-over-year to $8.0 million; the trailing twelve-month figure through Jun 2026 stood at $41.8 million (up 5.05% YoY), and the FY2025 full-year result was $36.7 million, down 10.25% from the prior year.
  • Operating Expenses fell to $8.0 million in Q2 2026 per SCYX's latest filing, from $16.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $28.9 million in Q4 2023 and bottomed at $8.0 million in Q2 2026.
  • Historically, Operating Expenses has averaged $14.5 million across 5 years, with a median of $11.4 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Operating Expenses slumped 68.71% in 2024, then jumped 91.03% in 2026.
  • Over 5 years, Operating Expenses stood at $24.0 million in 2022, then gained by 20.23% to $28.9 million in 2023, then plunged by 68.71% to $9.0 million in 2024, then decreased by 10.02% to $8.1 million in 2025, then slipped by 1.42% to $8.0 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $8.0 million, $16.9 million, and $8.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 367.83 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 8.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.01 Mn
Mar 31, 2026 16.94 Mn
Dec 31, 2025 8.13 Mn
Sep 30, 2025 8.74 Mn
Jun 30, 2025 10.93 Mn
Mar 31, 2025 8.87 Mn
Dec 31, 2024 9.03 Mn
Sep 30, 2024 10.98 Mn
Jun 30, 2024 9.97 Mn
Mar 31, 2024 10.88 Mn
Dec 31, 2023 28.86 Mn
Sep 30, 2023 11.86 Mn
Jun 30, 2023 14.94 Mn
Mar 31, 2023 11.81 Mn
Dec 31, 2022 24.01 Mn
Sep 30, 2022 23.36 Mn
Jun 30, 2022 23.06 Mn
Mar 31, 2022 20.43 Mn
Dec 31, 2021 22.89 Mn
Sep 30, 2021 19.96 Mn